Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Clinitech Laboratory Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Clinitech Laboratory Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Clinitech Laboratory - Announcement Under Reg 30 Of SEBI (LODR)- Update W.R.T Incorporation Of Subsidiary

    17 Feb 2026, 3:45PM Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 w.r.t Incorporation of Subsidiary of the company
  • Clinitech Laboratory - Board Meeting Outcome for Outcome Of 09Th Board Meeting Held Today At Its Registered Office

    6 Feb 2026, 3:41PM We hereby inform that the Board of Directors of the company, at its meeting held today i.e., February 06, 2026 held at registered office, without inti
  • Clinitech Laboratory - Board Meeting Outcome for Outcome Of 08Th Board Meeting For FY 2025-26 Thorugh Video Conferencing

    27 Jan 2026, 12:29PM Outcome of 08th Board meeting for FY 2025-26 through video conferencing without intimation for the following agendas:\r\n Approved the formation of a
  • Clinitech Laboratory - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jan 2026, 6:18PM Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended December 31, 2025
  • Clinitech Laboratory - General Update W.R.T Incorporation Of Subsidiary Of The Company

    19 Dec 2025, 5:21PM Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 w.r.t Incorporation of Subsidiary of the company

Key fundamentals

Evaluate the intrinsic value of Clinitech Laboratory Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 8.8304 4.4113 3.4099 2.7342
Liabilities 8.8304 4.4113 3.4099 2.7342
Equity 2.2824 1.68 1.5 1.5
Gross Profit 0.8318 0.9804 1.351 1.0665
Net Profit 0.3947 0.3712 0.6131 0.5126
Cash From Operating Activities -0.8787 -1.3989 1.2475 0.9557
NPM(%) 4.79 5.79 9.65 8.02
Revenue 8.2349 6.403 6.3475 6.3843
Expenses 7.4031 5.4226 4.9965 5.3178
ROE(%) 4.32 4.06 6.71 5.61

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Clinitech Laboratory Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 708.70 -0.24 42.25 25.11 301.39 0.70
Lotus Eye Hospital and Institute Ltd 111.00 1.83 355.45 91.50 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.92 1.53 0.00 189.99 -39.50 0.00
Astec Lifesciences Ltd 623.95 -0.13 0.00 86.29 -604.75 0.00

Company Info

Our Company was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 under the Companies Act, 1956 with the Registrar of Companies, Mumbai bearing Registration number 201078. The status of the Company was changed to public limited and the name of our Company was changed to Clinitech Laboratory Limited vide Special Resolution dated July 24, 2023 pursuant to conversion of the Company into public limited Company. The fresh certificate of incorporation consequent to conversion was issued on August 25, 2023 by the Registrar of Companies, Mumbai. Our corporate identification number is U85195MH2010PLC201078.Major Events and Milestones:2010-Incorporation of our Company.2012-Established new Lab at Kalyan2016-NABL Accreditation at Airoli Centre2018-Established new Lab at Thane2021-NABL Accreditation for SARS-COV-2 testing-Signed up agreements for Diagnostic Centre at Kharghar2022-Signed up agreements for Diagnostic Centre at Panvel / Badlapur2023-Converted Company to Limited-Established new Lab at Murbad

Our Company was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 under the Companies Act, 1956 with the Registrar of Companies, Mumbai bearing Registration number 201078. The status of the Company was changed to public limited and the name of our Company was changed to Clinitech Laboratory Limited vide Special Resolution dated July 24, 2023 pursuant to conversion of the Company into public limited Company. The fresh certificate of incorporation consequent to conversion was issued on August 25, 2023 by the Registrar of Companies, Mumbai. Our corporate identification number is U85195MH2010PLC201078.Major Events and Milestones:2010-Incorporation of our Company.2012-Established new Lab at Kalyan2016-NABL Accreditation at Airoli Centre2018-Established new Lab at Thane2021-NABL Accreditation for SARS-COV-2 testing-Signed up agreements for Diagnostic Centre at Kharghar2022-Signed up agreements for Diagnostic Centre at Panvel / Badlapur2023-Converted Company to Limited-Established new Lab at Murbad

Read More

Parent Organisation

Clinitech Laboratory Ltd.

Founded

19/03/2010

Managing Director

Mr.Jagdish Umakant Nayak

NSE Symbol

FAQ

The current price of Clinitech Laboratory Ltd is

The 52-week high for Clinitech Laboratory Ltd is

The market capitalization of Clinitech Laboratory Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Clinitech Laboratory Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Clinitech Laboratory Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Clinitech Laboratory Ltd shares.

The CEO of Clinitech Laboratory Ltd is Mr.Jagdish Umakant Nayak, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT